Literature DB >> 11506409

Nonprogressive autosomal recessive ataxia maps to chromosome 9q34-9qter in a large consanguineous Lebanese family.

V Delague1, C Bareil, P Bouvagnet, N Salem, E Chouery, J Loiselet, A Mégarbané, M Claustres.   

Abstract

Congenital ataxias are a heterogeneous group of predominantly nonprogressive disorders characterized by hypotonia, developmental delay followed by the appearance of ataxia, and often associated with dysarthria, mental retardation, and atrophy of the cerebellum. We performed a genome-wide screen on a large inbred Lebanese family presenting a nonprogressive autosomal recessive congenital cerebellar ataxia associated with short stature (MIM 213200), already described by Mégarbané and colleagues. The disease locus was assigned to a 12.1 cM interval on chromosome 9q34-9qter between D9S67 and D9S312. Differential diagnosis with other hereditary ataxias linked to the same region is discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11506409

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

1.  CAMOS, a nonprogressive, autosomal recessive, congenital cerebellar ataxia, is caused by a mutant zinc-finger protein, ZNF592.

Authors:  Elsa Nicolas; Yannick Poitelon; Eliane Chouery; Nabiha Salem; Nicolas Levy; André Mégarbané; Valérie Delague
Journal:  Eur J Hum Genet       Date:  2010-06-09       Impact factor: 4.246

2.  A review of the diverse genetic disorders in the Lebanese population: highlighting the urgency for community genetic services.

Authors:  Ghunwa Nakouzi; Khalil Kreidieh; Soha Yazbek
Journal:  J Community Genet       Date:  2014-09-27

3.  PMPCA mutations cause abnormal mitochondrial protein processing in patients with non-progressive cerebellar ataxia.

Authors:  Rebekah K Jobling; Mirna Assoum; Oleksandr Gakh; Susan Blaser; Julian A Raiman; Cyril Mignot; Emmanuel Roze; Alexandra Dürr; Alexis Brice; Nicolas Lévy; Chitra Prasad; Tara Paton; Andrew D Paterson; Nicole M Roslin; Christian R Marshall; Jean-Pierre Desvignes; Nathalie Roëckel-Trevisiol; Stephen W Scherer; Guy A Rouleau; André Mégarbané; Grazia Isaya; Valérie Delague; Grace Yoon
Journal:  Brain       Date:  2015-03-25       Impact factor: 13.501

Review 4.  Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy.

Authors:  Nicola Specchio; Alessandro Ferretti; Marina Trivisano; Nicola Pietrafusa; Chiara Pepi; Costanza Calabrese; Susanna Livadiotti; Alessandra Simonetti; Paolo Rossi; Paolo Curatolo; Federico Vigevano
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

5.  Advances in the Treatment of Neuronal Ceroid Lipofuscinosis.

Authors:  Jonathan B Rosenberg; Alvin Chen; Stephen M Kaminsky; Ronald G Crystal; Dolan Sondhi
Journal:  Expert Opin Orphan Drugs       Date:  2019-11-27       Impact factor: 0.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.